← Leaderboards
Fayez F Safadi
Northeast Ohio Medical University
$5,848,966
Attributed
$6,563,474
Total exposure
6
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $773.7K · FY2005–25$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,563,474 · 6
By mechanism
R01$5,709,303 · 3
R43$628,421 · 2
R03$225,750 · 1
Top collaborators
- Moses O Oyewumi2 shared
- Hope Ball1 shared
- Thomas Siosi Mbimba1 shared
Most similar at Northeast Ohio Medical University
Same institution · by research overlap
- Moses O Oyewumi$478,298
- Trinity Kronk$42,720
Others in their field
Top investigators on “Bone”
- David Heimbrook · Leidos Biomedical Research, Inc.$240,577,094
- Charles A Coltman · Southwest Oncology Group$141,983,231
- Mary M Horowitz · Medical College Of Wisconsin$136,789,389
- Gregory D Peterson · University Of Tennessee Knoxville$84,527,696
- Richard A Gibbs · Baylor College Of Medicine$64,141,825
- Jeffrey Krischer · University Of South Florida$61,545,982
Research focus
BoneOsteogenesisProteinsIn VivoOsteoblastsSignal TransductionMediatingBone MassKnockout MiceBone CellClinically SignificantDiagnosisOsteoporosisBone LossIn VitroMolecularMutationOsteoclastsHealthcareGenesOsteopeniaIntegrinsGene ExpressionNovel Therapeutic Intervention
Grant awards (23)
Delivery of GPNMB Therapeutics for Bone Regeneration$394,202
R01 · FY2025 · AR
The Role of TRAPPC9 in Osteoclast Differentiation and Function$338,049
R01 · FY2025 · AR · contact PI
Delivery of GPNMB Therapeutics for Bone Regeneration$406,394
R01 · FY2024 · AR
The Role of TRAPPC9 in Osteoclast Differentiation and Function$367,335
R01 · FY2024 · AR · contact PI
The Role of TRAPPC9 in Osteoclast Differentiation and Function$341,377
R01 · FY2022 · AR · contact PI
The Role of TRAPPC9 in Osteoclast Differentiation and Function$337,764
R01 · FY2021 · AR · contact PI
The Therapeutic Role of GPNMB in Osteoarthritis$319,822
R43 · FY2021 · AG
The Role of TRAPPC9 in Osteoclast Differentiation and Function$365,035
R01 · FY2020 · AR · contact PI
Osteoactivin Treatment for Accelerating Spinal Fusion in Osteoporosis$308,599
R43 · FY2019 · AG
The Role of Osteoactivin in Osteoblast Development and Function$312,848
R01 · FY2013 · AR · contact PI
The Role of Osteoactivin in Osteoblast Development and Function$329,314
R01 · FY2012 · AR · contact PI
The Role of Osteoactivin in Osteoblast Development and Function$187,650
R01 · FY2011 · AR · contact PI
The Role of Osteoactivin in Osteoblast Development and Function$131,295
R01 · FY2011 · AR · contact PI
The Role of Osteoactivin in Osteoblast Development and Function$334,125
R01 · FY2010 · AR · contact PI
The Role of Osteoactivin in Osteoblast Development and Function$337,500
R01 · FY2009 · AR · contact PI
OSTEOACTIVIN IN OSTEOBLAST DEVELOPMENT AND FUNCTION$285,077
R01 · FY2006 · AR · contact PI
OSTEOACTIVIN IN OSTEOBLAST DEVELOPMENT AND FUNCTION$291,938
R01 · FY2005 · AR
OSTEOACTIVIN IN OSTEOBLAST DEVELOPMENT AND FUNCTION$317,250
R01 · FY2004 · AR
OSTEOACTIVIN IN OSTEOBLAST DEVELOPMENT AND FUNCTION$317,250
R01 · FY2003 · AR
The Role of CDK4 in Bone Formation$75,250
R03 · FY2003 · AR
OSTEOACTIVIN IN OSTEOBLAST DEVELOPMENT AND FUNCTION$314,900
R01 · FY2002 · AR
The Role of CDK4 in Bone Formation$75,250
R03 · FY2002 · AR
The Role of CDK4 in Bone Formation$75,250
R03 · FY2001 · AR